We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Rapid 10-minute Liver MRI

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01390194
First Posted: July 8, 2011
Last Update Posted: November 13, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Philips Medical Systems
Bracco Diagnostics, Inc
Information provided by (Responsible Party):
University of Nebraska
  Purpose
The purpose of this study to assess the image quality of the rapid MRI compared to the standard MRI.

Condition
Underlying Liver Disease Hepatitis Fibrosis of Liver Cirrhosis With Suspicion of Liver Cancer Lesion on a Prior Ultrasound, CT or Outside MRI

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: A Rapid 10-minute Liver MRI

Resource links provided by NLM:


Further study details as provided by University of Nebraska:

Primary Outcome Measures:
  • image quality outcome [ Time Frame: 2 years ]
    Two MRI exams will be evaluated by two radiologists based on a number of items.


Enrollment: 25
Study Start Date: July 2011
Study Completion Date: June 2015
Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
subjects with an underlying liver disease
(1)underlying liver disease; (2) have a lesion on a prior imaging study; (3) must be prior standard MR

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with an underlying liver disease
Criteria

Inclusion Criteria:

  1. underlying liver disease
  2. have a lesion on a prior imaging study
  3. must have prior standard MR

Exclusion Criteria:

  1. Contra-indication for MR imaging including pacemaker, claustrophobia, pregnancy, electronic or vascular devices that are contraindicated;
  2. patients with severe kidney dysfunction
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01390194


Locations
United States, Nebraska
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198-1045
Sponsors and Collaborators
University of Nebraska
Philips Medical Systems
Bracco Diagnostics, Inc
Investigators
Principal Investigator: Shahid Hussain, MD University of Nebraska
  More Information

Responsible Party: University of Nebraska
ClinicalTrials.gov Identifier: NCT01390194     History of Changes
Other Study ID Numbers: 246-10
First Submitted: July 6, 2011
First Posted: July 8, 2011
Last Update Posted: November 13, 2015
Last Verified: November 2015

Keywords provided by University of Nebraska:
liver disease
hepatocellular carcinoma

Additional relevant MeSH terms:
Liver Diseases
Liver Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Neoplasms by Site
Neoplasms